Valuation: HANDOK Inc.

Market Cap 106B 79.08M 70.49M 65.41M 59.58M 112M 7.51B 114M 787M 308M 3.91B 296M 290M 12.53B P/E 2024
-3.16x
P/E 2025 -69x
Enterprise Value 457B 341M 304M 282M 257M 483M 32.35B 492M 3.39B 1.33B 16.85B 1.28B 1.25B 53.95B EV / Sales 2024
0.95x
EV / Sales 2025 0.93x
Free-Float
52.22%
Yield 2024
1.66%
Yield 2025 -
1 day-1.81%
1 week-5.66%
Current month-3.20%
1 month-13.47%
3 months+3.29%
6 months-19.76%
Current year-27.14%
1 week 7,970
Extreme 7970
8,600
1 month 7,970
Extreme 7970
9,360
Current year 6,460
Extreme 6460
11,820
1 year 6,460
Extreme 6460
12,150
3 years 6,460
Extreme 6460
20,300
5 years 6,460
Extreme 6460
24,800
10 years 6,460
Extreme 6460
44,750
Manager TitleAgeSince
Chief Executive Officer 69 -
Chief Executive Officer 68 1995-12-31
Director of Finance/CFO 58 -
Director TitleAgeSince
Chairman 68 1995-12-31
Director/Board Member 69 -
Director/Board Member 58 -
Change 5-day change 1-year change 3-year change Capi.($)
-1.81%-5.66%-29.96%-34.93% 80.44M
+3.55%+5.29%+54.07%+105.45% 1,077B
-0.25%-2.00%+32.71%+61.48% 612B
+0.59%+4.44%+23.69%+91.54% 501B
-1.48%+1.68%+71.42%+39.59% 364B
+2.37%+5.47%+32.67%+48.87% 353B
+2.64%+4.90%+21.01%+43.85% 278B
+3.24%+4.25%-0.31%+15.71% 251B
+1.86%+5.07%+47.70%+52.77% 230B
+2.49%+7.16%+32.82%+102.67% 190B
Average +1.53%+1.26%+28.58%+52.70% 385.66B
Weighted average by Cap. +1.47%+1.58%+39.06%+71.71%

Financials

2024 2025
Net sales 507B 378M 337M 313M 285M 537M 35.96B 546M 3.76B 1.47B 18.73B 1.42B 1.39B 59.96B 535B 399M 356M 330M 301M 566M 37.92B 576M 3.97B 1.55B 19.75B 1.5B 1.47B 63.24B
Net income -52.56B -39.21M -34.95M -32.43M -29.54M -55.61M -3.73B -56.61M -390M -153M -1.94B -147M -144M -6.21B -2.15B -1.61M -1.43M -1.33M -1.21M -2.28M -153M -2.32M -15.98M -6.25M -79.47M -6.02M -5.89M -254M
Net Debt 317B 237M 211M 196M 178M 336M 22.49B 342M 2.35B 922M 11.71B 888M 869M 37.5B 351B 261M 233M 216M 197M 371M 24.84B 377M 2.6B 1.02B 12.94B 980M 960M 41.42B
Projected Income Statement - Annual - HANDOK Inc.
Logo HANDOK Inc.
Handok Inc is a Korea-based company primarily engaged in the manufacture and sale of pharmaceuticals. The Company operates its business through four segments. The Pharmaceutical segment mainly manufactures and sells prescription and over-the-counter drugs, including treatments for diabetes, hypertension, kidney diseases, respiratory diseases, central nervous system disorders, rare diseases, as well as anticancer drugs. The Medical Device segment mainly sells medical devices and diagnostic reagents. The Contract Manufacturing segment mainly provides contract manufacturing and quality control services for pharmaceuticals. The Real Estate Leasing segment mainly engages in the real estate leasing business.
Employees
910
Date Price Change Volume
26-10-15 ₩8,160.00 -1.81% 7,076
26-10-14 ₩8,310.00 +1.84% 4,885
26-10-13 ₩8,160.00 -1.57% 3,503
26-10-12 ₩8,290.00 -3.60% 2,311
26-10-08 ₩8,600.00 -0.58% 2,592
  1. Stock Market
  2. Stocks
  3. A002390 Stock